Adjuvant testosterone therapy in chronic heart failure (ATTIC): a randomised open-label trial
This study involves human participants and was approved by institutional ethical committee, DHR Reg: EC/NEW/Inst/2020/1046CDSCO, Reg No: ECR/736/Inst/UK/2015/RR-18. Participants gave informed consent to participate in the study before taking part.
Trial registration number
(CTRI)—REF/2020/12/030292.
Source: BMJ Open - Category: General Medicine Authors: Dhar, M., Mittal, K., Parchani, A., Sharma, M., Bahurupi, Y., Kalra, S., Bhat, N. K. Tags: Open access, Geriatric medicine Source Type: research
More News: AndroGel | Brain | Cardiology | Drugs & Pharmacology | General Medicine | Geriatrics | Heart | Heart Failure | Medical Ethics | Neurology | Statistics | Students | Study | Universities & Medical Training